At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m (1) TP).

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

TSMC makes the most advanced semiconductors in the world. They are the tiny electronic “brains” that power most modern ...

A company that formulates pharmaceuticals in a sterile environment is spending almost $30 million to expand its headquarters ...

Researchers at the Paul Scherrer Institute PSI have achieved a breakthrough on the path to practical application of lithium ...